COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 719
[154] Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K. Natural
cytotoxic activity of peripheral-blood lymphocytes and cancer
incidence: an 11-year follow-up study of a general population.
Lancet. 2000;356(9244):1795-1799.
[155] Koelwyn GJ, Wennerberg E, Demaria S, Jones LW. Exercise in
Regulation of Inflammation-Immune Axis Function in Cancer
Initiation and Progression. Oncology (Williston Park).
2015;29(12):908-920, 922.
[156] Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G.
Immunological Effects of Conventional Chemotherapy and
Targeted Anticancer Agents. Cancer Cell. 2015;28(6):690-714.
[157] Sharma P, Allison JP. The future of immune checkpoint
therapy. Science. 2015;348(6230):56-61.
[158] Ribas A, Wolchok JD. Cancer immunotherapy using
checkpoint blockade. Science. 2018;359(6382):1350-1355.
[159] Williams KM, Hakim FT, Gress RE. T cell immune reconstitution
following lymphodepletion. Semin Immunol. 2007;19(5):318-330.
[160] Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G.
Immunological Effects of Conventional Chemotherapy and
Targeted Anticancer Agents. Cancer Cell. 2015;28(6):690-714.
[161] Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID
[162] Brodin P. Immune determinants of COVID-19 disease
presentation and severity. Nat Med. 2021;27(1):28-33.
[163] Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions
of natural killer cells. Nat Immunol. 2008;9(5):503-510.
[164] Klenerman P, Cerundolo V. Exhaustion revived. Nat Immunol.
2020;21(8):836-838.
[165] Wherry EJ, Kurachi M. Molecular and cellular insights into T
cell exhaustion. Nat Rev Immunol. 2015;15(8):486-499.
719
